Effect of E3040, an inhibitor of 5-lipoxygenase and thromboxane synthase, on rat bowel damage induced by lipopolysaccharide

By Oketani K.   Inoue T.   Murakami M.  

European Journal of Pharmacology, Vol. 427, Iss. 2, 2001-09 ,pp. : 159-166

Elsevier

Access to resources Recommend Favorite

G 619, a dual thromboxane synthase inhibitor and thromboxane A 2 receptor antagonist, inhibits tumor necrosis factor- biosynthesis

By Altavilla D.   Squadrito F.   Canale P.   Ioculano M.   Squadrito G.   Campo G.M.   Serrano M.   Sardella A.   Urna G.   Spignoli G.   Caputi A.P.  

European Journal of Pharmacology, Vol. 286, Iss. 1, 1995-11 ,pp. : 31-39

Elsevier

Access to resources Recommend Favorite

Dual effects of auranofin on prostaglandin E 2 production by rat peritoneal macrophages

By Yamashita M.   Niki H.   Yamada M.   Watanabe-Kobayashi M.   Mue S.   Ohuchi K.  

European Journal of Pharmacology, Vol. 325, Iss. 2, 1997-05 ,pp. : 221-227

Elsevier

Access to resources Recommend Favorite

Correlative Alteration of Thromboxane A2 with Antigen-Induced Bronchoconstriction and the Role of Platelets As a Source of Txa2 Synthesis in Guinea Pigs: Effect of Dp-1904, an Inhibitor of Thromboxane Synthetase

By Takami M.   Tsukada W.  

Pharmacological Research, Vol. 38, Iss. 2, 1998-07 ,pp. : 133-139

Academic Press

Access to resources Recommend Favorite

Anti-inflammatory activities of LDP-392, A dual PAF receptor antagonist and 5-lipoxygenase inhibitor

By Qian C.     Libertine-Garahan L.   Eckman J.B.   Cai X.   Scannell R.T.   Yeh C.G.  

Pharmacological Research, Vol. 44, Iss. 3, 2001-09 ,pp. : 213-220

Academic Press

Access to resources Recommend Favorite